Switch to:

Ampio Pharmaceuticals Inc (AMPE) Ownership Data

Short Interest History (%)

This is the historical short interest of Ampio Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Institutional Ownership History (%)

This the Institutional Ownership History of Ampio Pharmaceuticals Inc Peter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Ampio Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

HolderShares% of Shares
Outstanding
Report Date
Michael Macaluso1,786,7523.44%2013-11-27
Donald B. Wingerter,Jr325,0000.63%2011-05-18
Mr. Richard B. Giles186,5590.36%2014-01-02
Mark D. Mcgregor20,000less than 0.1%2011-05-18
Mr. Philip H. Coelho16,193less than 0.1%2014-01-02
Dr. David R. Stevens,PhD6,255less than 0.1%2014-01-02

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Knoll Capital Management LP3,370,8222014-09-306.544.7112,000,000
ACT Capital Management LLLP2,788,6002013-12-316.630.0019,882,718
BlackRock Fund Advisors1,681,1072014-09-303.230.005,934,000
Vanguard Group, Inc.1,309,8982014-09-302.520.004,624,000
Talkot Capital, LLC842,9952014-09-301.622.092,976,000
iShares Russell 2000 (AU)692,3842014-12-241.340.012,374,877
Vanguard Total Stock Mkt Idx679,5512014-11-301.310.002,310,473
State Street Corp460,7422014-09-300.890.001,626,000
Northern Trust Investments, N.A.435,6742014-09-300.840.001,538,000
Vanguard Extended Market Index Fund366,5512014-11-300.710.001,246,273

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK